Navigation Links
New research finds potential risk for millions in Africa believed resistant to vivax malaria
Date:11/15/2013

Washington, D.C. (November 14, 2013)Provocative new research shows that the Plasmodium vivax parasite, responsible for nearly 20 million cases of malaria in 2010, may be "rapidly evolving" to overcome the natural resistance conferred by a blood type found in millions of Africans, scientists reported today at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

In large swaths of sub-Saharan Africa, some 95 percent or more of the population have been considered protected from vivax malaria because of something they lack on their red blood cells: the "Duffy blood group protein." The absence of this protein has been well known for decades to hinder the ability of invading vivax malaria parasites to gain entry into red blood cells.

But over the last five years malaria researchers have been surprised to see a growing number of reports from Africa and South America of infections in people who are Duffy-negative and should be resistant to vivax malaria. While not regarded to be as deadly as malaria caused by the Plasmodium falciparum parasite, vivax malaria threatens almost as many people worldwide--some 2.49 billion are at risk. But that number could be significantly higher if the blood type is not as fully protective as previously believed.

"We discovered previously unknown genetic mechanisms in the P. vivax parasite that could give it other ways to invade red blood cells and help explain why we are seeing these vivax malaria infections in people who are Duffy-negative," said Peter Zimmerman, PhD, of Case-Western Reserve University, a co-author of two new studies to be published November 21 and December 5 in the journal PLOS Neglected Tropical Diseases.

The studies conclude that vivax malaria appears to be "rapidly evolving" and also find that previous genome sequence analyses may have missed "important genes" that allow the parasite to make people sick.
'/>"/>

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722

Bridget DeSimone
bdesimone@burnesscommunications.com
301.280.5735

American Society of Tropical Medicine and Hygiene
Source:Eurekalert


Page: 1 2 3 4

Related biology news :

1. Northeastern researchers have discovered a new treatment to cure MRSA infection
2. Novel aspects of histamine research discussed in Versita open access book
3. Danish researchers predict risk of valvular heart disease
4. Researcher finds potential new use for old drugs
5. Using morphine after abdominal surgery may prolong pain, CU-Boulder researchers find
6. Wayne State researchers discover specific inhibitor for rheumatoid arthritis treatment
7. Protein illustrates muscle damage: McMaster researchers
8. Mainz University collaborates with 3 Chinese universities in research and teaching
9. F1000Research launch data plotting tool
10. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
11. Research by Saint Louis University scientists offers way to disrupt fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 ... and technological advancement to drive biometric systems market ... 2020   According to a recently ... Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... register growth at CAGR of over 22% through ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... / b3c newswire / - Critical Outcome ... today from animal experiments carried out at a prominent ... adds to the already impressive data package for COTI-2, ... with first line therapies with low toxicity in seven ...
... of cancer mortality in children. Even if a cure ... stressful treatment which can be harmful to the developing ... gentle treatment methods. The most important childhood brain tumors ... young patients each year in Germany, and pylocytic astrocytoma, ...
... This release is available in Spanish . ... understand the trophic food chains involving microbian plankton. That is, to ... that live organisms can be classified from the perspective of nutrition. ... these levels are united one to the other, forming a chain. ...
Cached Biology News:ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4University of the Basque Country research on plankton at Urdaibai 2
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ - Aptose Biosciences Inc. ... developing new therapeutics that target the underlying mechanisms of ... Administration (FDA) has granted the company orphan drug designation ... (AML). APTO-253, a first-in-class inducer of the KLF4 gene, ... Ib clinical trial in patients with AML, high-risk myelodysplastic ...
(Date:6/2/2015)... DUBLIN , June 02, 2015 ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:6/2/2015)... 2015   Y-Prime, Inc ., announced today ... 2015 in Philadelphia , June ... gathering, allows influential decision makers from the Biotech ... evaluate emerging technologies such as YPrime. ... design, implementation and management of Interactive Response Technology ...
(Date:6/2/2015)... , June 2, 2015  RXi ... biotechnology company focused on discovering and developing ... dermatology and ophthalmology, today announced that Dr. ... will present at the 23 rd ... world congress will include in-depth presentations by ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 2Global Biomarkers Market Report 2015 - Technologies, Markets and Companies Analysis and Forecasts 2014-2024 3YPrime at BIO Exhibition in Philadelphia and DIA in Washington DC during the month of June 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4
... -- Rita Colwell, former director of the National Science ... Health" at 5:30 p.m. Monday, Oct. 3, in a ... Union. , ,Colwell headed the NSF from 1998-2004. She ... a distinguished professor at the University of Maryland and ...
... acquire healthcare information technology provider IDX Systems Corp. ... Thursday. The transaction is expected to close by early ... complementary product lines," said GE Healthcare Vice President Don ... comprehensive product line across radiology systems, across electronic health ...
... -- Third Wave Technologies Inc. , a developer ... analysis applications, is being sued by Belgium-based Innogenetics N.V. ... Meanwhile, in a separate case, Third Wave has won a ... is a provider of diagnostic and therapeutic products, with a ...
Cached Biology Technology:Third Wave sued by one firm; gets injunction against another 2
Goat polyclonal to Sarcosine Oxidase ( Abpromise for all tested applications). Antigen: Microbial Sarcosine Oxidase. Entrez Gene ID: 51268 Swiss Protein ID: Q6IAJ9...
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Rabbit polyclonal to FANCG ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSRQTTSVGSSC, corresponding to amino acids 1 - 12 of Human FANCG. Entrez GeneID: 2189 Swis...
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6...
Biology Products: